KIT and neoplasm: TrkAIII transfectants also exhibit elevated expression of the NB tumour stem cell-markers CD117, SOX2, Nestin and Nanog, indicating that TrkAIII not only blocks NGF/TrkA-induced NB cell differentiation but also promotes a more NB tumour stem cell-like phenotype.